Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods

The SARS-CoV-2 infection manifests with diverse clinical manifestations, with severity potentially influenced by the viral variant. COVID-19 has also been shown to impact ocular microcirculation in some patients, but whether this effect varies by viral lineage remains unclear. This prospective study...

Full description

Saved in:
Bibliographic Details
Main Authors: Magdalena Kal, Michał Brzdęk, Izabella Karska-Basta, Piotr Rzymski, Antonio Pinna, Jerzy Mackiewicz, Dominik Odrobina, Dorota Zarębska-Michaluk, Robert Flisiak
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/17/1/47
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832587335562166272
author Magdalena Kal
Michał Brzdęk
Izabella Karska-Basta
Piotr Rzymski
Antonio Pinna
Jerzy Mackiewicz
Dominik Odrobina
Dorota Zarębska-Michaluk
Robert Flisiak
author_facet Magdalena Kal
Michał Brzdęk
Izabella Karska-Basta
Piotr Rzymski
Antonio Pinna
Jerzy Mackiewicz
Dominik Odrobina
Dorota Zarębska-Michaluk
Robert Flisiak
author_sort Magdalena Kal
collection DOAJ
description The SARS-CoV-2 infection manifests with diverse clinical manifestations, with severity potentially influenced by the viral variant. COVID-19 has also been shown to impact ocular microcirculation in some patients, but whether this effect varies by viral lineage remains unclear. This prospective study compared clinical features and ocular parameters assessed via optical coherence tomography angiography (OCTA) in patients recovering from SARS-CoV-2 infections during the dominance of two distinctive viral lineages, Alpha (B.1.1.7) and Delta (B.1.617.2), and compared them to a control group. The following parameters were measured: vessel density (VD) in the superficial capillary plexus (SCP), deep capillary plexus (DCP), and choriocapillaris (CCP) using OCTA, with a manual assessment of the foveal avascular zones in the SCP (FAZs) and DCP (FAZd). A control group was also included. Among 63 patients in the Alpha group and 41 in the Delta group, no eye-related symptoms were reported during the examination. However, the Delta group showed significantly lower VD in the SCP and DCP across all quadrants (<i>p</i> < 0.001–0.039), while the Alpha group showed reduced VD in the foveal CCP (<i>p</i> = 0.005) and significantly wider FAZs and FAZd (<i>p</i> = 0.002 for both). In conclusion, ocular microcirculatory changes differed between the two variants, with Alpha associated with foveal choroidal VD reduction and larger FAZs and Delta linked to lower SCP and DCP VD across multiple regions. These findings highlight the potential for SARS-CoV-2 variants to differentially impact ocular vasculature, underscoring the need for variant-specific follow-up in COVID-19 patients.
format Article
id doaj-art-0f9ab3143110434ca67826cd314be556
institution Kabale University
issn 1999-4915
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj-art-0f9ab3143110434ca67826cd314be5562025-01-24T13:52:23ZengMDPI AGViruses1999-49152024-12-011714710.3390/v17010047Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance PeriodsMagdalena Kal0Michał Brzdęk1Izabella Karska-Basta2Piotr Rzymski3Antonio Pinna4Jerzy Mackiewicz5Dominik Odrobina6Dorota Zarębska-Michaluk7Robert Flisiak8Collegium Medicum, Jan Kochanowski University, 25-317 Kielce, PolandCollegium Medicum, Jan Kochanowski University, 25-317 Kielce, PolandDepartment of Ophthalmology, Faculty of Medicine, Jagiellonian University Medical College, 31-501 Krakow, PolandDepartment of Environmental Medicine, Poznan’ University of Medical Sciences, 60-806 Poznan, PolandDepartment of Medicine, Surgery, and Pharmacy, Ophthalmology Unit, University of Sassari, 07100 Sassari, ItalyDepartment of Vitreoretinal Surgery, Medical University of Lublin, 20-079 Lublin, PolandOphthalmic Clinic, The Voivodeship Hospital, 25-736 Kielce, PolandDepartment of Infectious Diseases and Allergology, Jan Kochanowski University, 25-317 Kielce, PolandDepartment of Infectious Diseases and Hepatology, Medical University of Białystok, 15-540 Białystok, PolandThe SARS-CoV-2 infection manifests with diverse clinical manifestations, with severity potentially influenced by the viral variant. COVID-19 has also been shown to impact ocular microcirculation in some patients, but whether this effect varies by viral lineage remains unclear. This prospective study compared clinical features and ocular parameters assessed via optical coherence tomography angiography (OCTA) in patients recovering from SARS-CoV-2 infections during the dominance of two distinctive viral lineages, Alpha (B.1.1.7) and Delta (B.1.617.2), and compared them to a control group. The following parameters were measured: vessel density (VD) in the superficial capillary plexus (SCP), deep capillary plexus (DCP), and choriocapillaris (CCP) using OCTA, with a manual assessment of the foveal avascular zones in the SCP (FAZs) and DCP (FAZd). A control group was also included. Among 63 patients in the Alpha group and 41 in the Delta group, no eye-related symptoms were reported during the examination. However, the Delta group showed significantly lower VD in the SCP and DCP across all quadrants (<i>p</i> < 0.001–0.039), while the Alpha group showed reduced VD in the foveal CCP (<i>p</i> = 0.005) and significantly wider FAZs and FAZd (<i>p</i> = 0.002 for both). In conclusion, ocular microcirculatory changes differed between the two variants, with Alpha associated with foveal choroidal VD reduction and larger FAZs and Delta linked to lower SCP and DCP VD across multiple regions. These findings highlight the potential for SARS-CoV-2 variants to differentially impact ocular vasculature, underscoring the need for variant-specific follow-up in COVID-19 patients.https://www.mdpi.com/1999-4915/17/1/47COVID-19Alpha variantDelta variantvessel densityoptical coherence tomography angiographyfoveal avascular zone
spellingShingle Magdalena Kal
Michał Brzdęk
Izabella Karska-Basta
Piotr Rzymski
Antonio Pinna
Jerzy Mackiewicz
Dominik Odrobina
Dorota Zarębska-Michaluk
Robert Flisiak
Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
Viruses
COVID-19
Alpha variant
Delta variant
vessel density
optical coherence tomography angiography
foveal avascular zone
title Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
title_full Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
title_fullStr Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
title_full_unstemmed Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
title_short Difference in Optical Coherence Tomography Angiography Parameters After SARS-CoV-2 Infection During the Alpha and Delta Variant Dominance Periods
title_sort difference in optical coherence tomography angiography parameters after sars cov 2 infection during the alpha and delta variant dominance periods
topic COVID-19
Alpha variant
Delta variant
vessel density
optical coherence tomography angiography
foveal avascular zone
url https://www.mdpi.com/1999-4915/17/1/47
work_keys_str_mv AT magdalenakal differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT michałbrzdek differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT izabellakarskabasta differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT piotrrzymski differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT antoniopinna differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT jerzymackiewicz differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT dominikodrobina differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT dorotazarebskamichaluk differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods
AT robertflisiak differenceinopticalcoherencetomographyangiographyparametersaftersarscov2infectionduringthealphaanddeltavariantdominanceperiods